Jia Liu

ORCID: 0000-0002-2070-7754
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Circular RNAs in diseases
  • Epigenetics and DNA Methylation
  • MicroRNA in disease regulation
  • RNA Research and Splicing
  • Cancer Genomics and Diagnostics
  • Ferroptosis and cancer prognosis
  • RNA Interference and Gene Delivery
  • Cancer-related gene regulation
  • Genetics and Neurodevelopmental Disorders
  • Histone Deacetylase Inhibitors Research
  • Mycobacterium research and diagnosis
  • Advanced biosensing and bioanalysis techniques
  • Genetic factors in colorectal cancer
  • Extracellular vesicles in disease
  • PI3K/AKT/mTOR signaling in cancer
  • Lung Cancer Treatments and Mutations
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Genomics and Rare Diseases
  • RNA regulation and disease
  • Insect Resistance and Genetics
  • Liver physiology and pathology
  • Pharmacogenetics and Drug Metabolism
  • Genomics, phytochemicals, and oxidative stress

Sun Yat-sen University
2018-2025

Chinese Academy of Sciences
2015-2025

Ningbo Institute of Industrial Technology
2024-2025

St Vincent's Hospital
2012-2025

Stomatology Hospital
2025

Peking University
2025

Theranostics (New Zealand)
2025

The Kinghorn Cancer Centre
2025

Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)
2025

Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai)
2025

Daniel J. Brat Roel G.W. Verhaak Kenneth D. Aldape W. K. Alfred Yung Sofie R. Salama and 95 more Lee Cooper Esther Rheinbay C. Ryan Miller Mark Vitucci Olena Morozova A. Gordon Robertson Houtan Noushmehr Peter W. Laird Andrew D. Cherniack Rehan Akbani Jason T. Huse Giovanni Ciriello Laila Poisson Jill S. Barnholtz‐Sloan Mitchel S. Berger Cameron Brennan Rivka R. Colen Howard Colman Adam E. Flanders Caterina Giannini Mia Grifford Antonio Iavarone Rajan Jain Isaac Joseph Jaegil Kim L. Sylvia Tom Mikkelsen Bradley A. Murray Brian Patrick O’Neill Lior Pachter D. Williams Parsons Carrie Sougnez Erik P. Sulman Scott R. VandenBerg Erwin G. Van Meir Andreas von Deimling Hailei Zhang Daniel Crain Kevin Lau David Mallery Scott Morris Joseph Paulauskis Robert Penny Troy Shelton Mark E. Sherman Peggy Yena Aaron Black Jay Bowen Katie Dicostanzo Julie M. Gastier‐Foster Kristen Leraas Tara M. Lichtenberg Christopher R. Pierson Nilsa C. Ramirez Cynthia Taylor Stephanie Weaver Lisa Wise Erik Zmuda Tanja M. Davidsen John A. Demchok Greg Eley Martin L. Ferguson Carolyn M. Hutter Kenna Shaw Bradley A. Ozenberger Margi Sheth Heidi J. Sofia Roy Tarnuzzer Linghua Wang Liming Yang Jean C. Zenklusen Brenda Ayala Julien Baboud Sudha Chudamani Mark A. Jensen Jia Liu Todd Pihl Rohini Raman Yunhu Wan Ye Wu Adrian Ally J. Todd Auman Miruna Balasundaram Saianand Balu Stephen B. Baylin Rameen Beroukhim Arnoud Boot Reanne Bowlby Christopher A. Bristow Denise Brooks Yaron S.N. Butterfield Rebecca Carlsen Scott L. Carter Lynda Chin Andy Chu

Diffuse low-grade and intermediate-grade gliomas (which together make up the lower-grade gliomas, World Health Organization grades II III) have highly variable clinical behavior that is not adequately predicted on basis of histologic class. Some are indolent; others quickly progress to glioblastoma. The uncertainty compounded by interobserver variability in diagnosis. Mutations IDH, TP53, ATRX codeletion chromosome arms 1p 19q (1p/19q codeletion) been implicated as clinically relevant...

10.1056/nejmoa1402121 article EN New England Journal of Medicine 2015-06-11
Ashton C. Berger Anil Korkut Rupa S. Kanchi Apurva M. Hegde Walter F. Lenoir and 95 more Wenbin Liu Yuexin Liu Huihui Fan Hui Shen Visweswaran Ravikumar Arvind Rao André Schultz Xubin Li Pavel Sumazin Cecilia Williams Pieter Mestdagh Preethi H. Gunaratne Christina Yau Reanne Bowlby A. Gordon Robertson Daniel Guimarães Tiezzi Chen Wang Andrew D. Cherniack Andrew K. Godwin Nicole M. Kuderer Janet S. Rader Rosemary E. Zuna Anil K. Sood Alexander J. Lazar Akinyemi I. Ojesina Clement Adebamowo Sally N. Adebamowo Keith Baggerly Ting-Wen Chen Hua‐Sheng Chiu Steve Lefever Liang Liu Karen L. MacKenzie Sandra Oršulić Jason Roszik Carl Simon Shelley Qianqian Song Christopher P. Vellano Nicolas Wentzensen John N. Weinstein Gordon B. Mills Douglas A. Levine Rehan Akbani Rory Johnson John A. Demchok Ina Felau Melpomeni Kasapi Martin L. Ferguson Carolyn M. Hutter Heidi J. Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C. Zenklusen Jiashan Zhang Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Juok Cho Timothy Defreitas Scott Frazer Nils Gehlenborg Gad Getz David I. Heiman Seungchan Kim Michael S. Lawrence Pei Lin Thomas J. Giordano Michael S. Noble Gordon Saksena Doug Voet Hailei Zhang Brady Bernard Nyasha Chambwe Varsha Dhankani Theo Knijnenburg Roger Kramer Kalle Leinonen Yuexin Liu Michael Miller Sheila M. Reynolds Ilya Shmulevich Vésteinn Thórsson Wei Zhang Rehan Akbani Bradley M. Broom Apurva M. Hegde Zhenlin Ju Rupa S. Kanchi Anil Korkut

We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique features, clinically significant subtypes, potential therapeutic targets. found 61 somatic copy-number alterations (SCNAs) 46 significantly mutated genes (SMGs). Eleven SCNAs 11 SMGs had not been identified in previous TCGA studies the individual tumor types. functionally estrogen receptor-regulated long non-coding RNAs (lncRNAs)...

10.1016/j.ccell.2018.03.014 article EN cc-by-nc-nd Cancer Cell 2018-04-01

Abstract Background Long noncoding RNAs (lncRNAs) play nonnegligible roles in the epigenetic regulation of cancer cells. This study aimed to identify a specific lncRNA that promotes colorectal (CRC) progression and could be potential therapeutic target. Methods We screened highly expressed lncRNAs human CRC samples compared with their matched adjacent normal tissues. The proteins interact LINRIS (Long Intergenic Noncoding RNA for IGF2BP2 Stability) were confirmed by pull-down...

10.1186/s12943-019-1105-0 article EN cc-by Molecular Cancer 2019-12-01

Highlights•MYC paralogs are significantly amplified (28% of all samples)•MYC antagonists mutated (MGA, 4% samples) or deleted (MNT, 10% alterations mutually exclusive with PIK3CA, PTEN, APC, BRAF alterations•Expression analysis reveals pan-cancer and tumor-specific MYC-associated pathwaysSummaryAlthough the MYC oncogene has been implicated in cancer, a systematic assessment MYC, related transcription factors, co-regulatory proteins, forming proximal network (PMN), across human cancers is...

10.1016/j.cels.2018.03.003 article EN cc-by Cell Systems 2018-03-01

Highlights•SCCs show chromosome or methylation alterations affecting multiple related genes•These regulate squamous stemness, differentiation, growth, survival, and inflammation•Copy-quiet SCCs have hypermethylated (FANCF, TET1) mutated (CASP8, MAPK-RAS) genes•Potential targets include ΔNp63, WEE1, IAPs, PI3K-mTOR/MAPK, immune responsesSummaryThis integrated, multiplatform PanCancer Atlas study co-mapped identified distinguishing molecular features of cell carcinomas (SCCs) from five sites...

10.1016/j.celrep.2018.03.063 article EN cc-by-nc-nd Cell Reports 2018-04-01

Necrosis is one of the main forms cardiomyocyte death in heart disease. Recent studies have demonstrated that certain types necrosis are regulated and programmed dependent on activation receptor-interacting serine/threonine-protein kinase (RIPK) 1 3 which may be negatively by Fas-associated protein with domain (FADD). In addition, microRNAs long noncoding RNAs been shown to play important roles various biological processes recently.The purpose this study was test hypothesis microRNA-103/107...

10.1161/circresaha.117.305781 article EN Circulation Research 2015-06-03

Abstract Tumor cells often reprogram their metabolism for rapid proliferation. The roles of long noncoding RNAs (lncRNAs) in remodeling and the underlying mechanisms remain elusive. Through screening, we found that lncRNA Actin Gamma 1 Pseudogene ( AGPG ) is required increased glycolysis activity cell proliferation esophageal squamous carcinoma (ESCC). Mechanistically, binds to stabilizes 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). By preventing APC/C-mediated...

10.1038/s41467-020-15112-3 article EN cc-by Nature Communications 2020-03-20

The WRKY family of transcription factors (TFs) functions as transcriptional activators or repressors in various signaling pathways. In this study, we discovered that OsWRKY62 and OsWRKY76, two genes the IIa subfamily, undergo constitutive inducible alternative splicing. full-length OsWRKY62.1 OsWRKY76.1 proteins formed homocomplexes heterocomplexes, heterocomplex dominates nuclei when analyzed Nicotiana benthamiana leaves. Transgenic overexpression rice (Oryza sativa) enhanced plant...

10.1104/pp.15.01921 article EN PLANT PHYSIOLOGY 2016-04-18

Abstract Epigenetic landscapes can shape physiologic and disease phenotypes. We used integrative, high resolution multi-omics methods to delineate the methylome landscape characterize oncogenic drivers of esophageal squamous cell carcinoma (ESCC). found 98% CpGs are hypomethylated across ESCC genome. Hypo-methylated regions enriched in areas with heterochromatin binding markers (H3K9me3, H3K27me3), while hyper-methylated polycomb repressive complex (EZH2/SUZ12) recognizing regions. Altered...

10.1038/s41467-020-17227-z article EN cc-by Nature Communications 2020-07-22

Abstract Emerging evidence highlights the key regulatory roles of long noncoding RNAs (lncRNAs) in initiation and progression numerous malignancies. The lncRNA identified as differentiation antagonizing nonprotein coding RNA (DANCR) is a novel widely involved development multiple human cancers. However, function DANCR its potential molecular mechanism cervical cancer remain unclear. In this study, we discovered that was significantly elevated tissues cells, closely correlated with poor...

10.1002/jcp.27484 article EN Journal of Cellular Physiology 2018-10-26

Abstract Long noncoding RNAs (lncRNA) are involved in tumorigenesis and drug resistance. However, the roles underlying mechanisms of lncRNAs colorectal cancer still unknown. In this work, through transcriptomic profiling analysis 21 paired tumor normal samples, we identified a novel cancer–related lncRNA, MNX1-AS1. MNX1-AS1 expression was significantly upregulated associated with poor prognosis. vitro vivo gain- loss-of-function experiments showed that promotes proliferation cells. bound to...

10.1158/0008-5472.can-20-3747 article EN Cancer Research 2021-03-29

Esophageal squamous cell carcinoma (ESCC) is one of the most common types cancer and leading causes cancer-related mortality worldwide, especially in Eastern Asia. Here, we downloaded microarray data lncRNA expression profiles ESCC patients from Gene Expression Omnibus (GEO) The Cancer Genome Atlas (TCGA) sets divided into training, validation test set. random survival forest (RSF) algorithm Cox regression analysis were applied to identify a seven-lncRNA signature. Then predictive ability...

10.1038/s41598-018-27307-2 article EN cc-by Scientific Reports 2018-06-05

Background: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous. Methods: We integrated genomic data comprehensively assess the association between pyroptosis tumor microenvironment (TME) cell-infiltrating characteristics in HCC, as well potential molecular function clinical significance of lncRNA. Results: The analysis CNV alteration frequency...

10.3389/fcell.2021.713925 article EN cc-by Frontiers in Cell and Developmental Biology 2021-11-15

Abstract Much effort has been dedicated to developing circulating tumor cells (CTC) as a noninvasive cancer biopsy, but with limited success yet. In this study, we combine method for isolation of highly pure CTCs using immunomagnetic enrichment/fluorescence-activated cell sorting advanced whole genome sequencing (WGS), based on long fragment read technology, illustrate the utility an accurate, comprehensive, phased, and quantitative genomic analysis platform CTCs. Whole genomes 34 from...

10.1158/0008-5472.can-17-0688 article EN Cancer Research 2017-08-14

The regulatory role of long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (

10.14348/molcells.2018.0180 article EN PubMed 2019-05-31

Esophageal squamous cell carcinoma (ESCC) is one of the most life- and health-threatening malignant diseases worldwide, especially in China. Long noncoding RNAs (lncRNAs) have emerged as important regulators tumorigenesis tumor progression. However, roles mechanisms lncRNAs ESCC require further exploration. Here, combination with a small interfering RNA (siRNA) library targeting specific lncRNAs, we performed MTS Transwell assays to screen functional that were overexpressed ESCC. TMPO-AS1...

10.1038/s12276-022-00791-3 article EN cc-by Experimental & Molecular Medicine 2022-06-27

The long noncoding RNA (lncRNA) Eosinophil Granule Ontogeny Transcript (EGOT) has been reported to inhibit the proliferation and migration of glioma cells, promote development progression gastric cancer through Hedgehog (Hh) signaling pathway. This study was conducted assess role EGOT in breast cancer. We observed that is significantly down-regulated tissues cell lines, expression negatively correlated with Ki67 expression. Overexpression BT549 cells decreased viability migration. In...

10.1002/2211-5463.12833 article EN cc-by FEBS Open Bio 2020-03-09

Metastasis accounts for poor prognosis of cancers and related deaths. Accumulating evidence has shown that long noncoding RNAs (lncRNAs) play critical roles in several types cancer. However, which lncRNAs contribute to metastasis colon cancer is still largely unknown. In this study, we found lncRNA LINC01578 was correlated with upregulated cancer, associated metastasis, advanced clinical stages, overall survival, disease-specific disease-free survival. Gain-of-function loss-of-function...

10.1002/1878-0261.12819 article EN cc-by Molecular Oncology 2020-10-11
Coming Soon ...